|
Derma Sciences, Inc. is a global medical device / pharmaceutical company focused on wound care. Over the past 3 years, we have successfully launched several novel advanced wound care products. We also have a drug in development for dermal repair and scar prevention / reduction. Another key part of our business is the OEM / private labeling of a full line of commodity wound care dressings. In all, we are a strong wound care company - growing in our current markets and expanding internationally.
More about Derma Sciences
Edward J. Quilty has served as Chief Executive Officer of the Company since November, 1996, Chairman of the Board since May, 1996 and as a Director of the Company since March, 1996. Mr. Quilty was the Chairman of the Board of Palatin Technologies, Inc., a publicly traded biopharmaceutical company specializing in peptide drug design for diagnostic and therapeutic agents from November, 1995 until May, 2000. 
John E. Yetter, CPA has served as Vice President and Chief Financial Officer of the Company since August, 2000. Prior to joining the Company, Mr. Yetter held a variety of senior financial positions with Bristol-Myers Squibb Company. Before his association with Bristol-Myers Squibb, he held several supervisory financial positions with Cooper Industries, Inc., Price Waterhouse and Hulse Manufacturing Company. Mr. Yetter is a member of the American Institute of Certified Public Accountants and the New York Society of Certified Public Accountants. He earned a Bachelor of Science in Accounting, magna cum laude, from Boston College School of Management, Boston, Massachusetts in 1975. 
Robert C. Cole assumed the office of Executive Vice President for Sales of the Company in 2006. Previously, he served as the Company's Vice President - Sales and Marketing since January, 2003. Prior to joining the Company, Mr. Cole held a variety of executive sales positions with B. Braun Medical and predecessor firms beginning in 1974, most recently as Vice President, Sales, Eastern Zone. Mr. Cole earned his Bachelor of Science degree in Biology, cum laude, from St. Vincent's College, Latrobe, Pennsylvania, in 1974. 
Frederic Eigner has served as Executive Vice President for Operations of the Company and General Manager of the Company's Canadian subsidiary, Derma Sciences Canada Inc., since March, 2005. Previously he served as Vice President for Operations of Derma Sciences Canada Inc. since August, 2002. Prior to its acquisition by the Company, he held several positions with Dumex Medical Inc. during the period 1992 until August of 2002, most recently as Executive Vice President. Prior to his association with Dumex Medical, Mr. Eigner held a variety of executive manufacturing positions with The Kendall Company during the period 1980 through 1992, most recently as Director of Manufacturing. He earned a Bachelor of Science degree in Industrial Engineering from the High Technical school of Kranj, Slovenia, in 1975, a Master of Science in Chemical Engineering from the University of Maribor, Slovenia, in 1980, and a Master of Business Administration from the University of Toronto, Ontario, Canada, in 2000. 
Barry Wolfenson has served as EVP of Global Marketing & Business Development for Derma Sciences since March 2010. Previously, Mr. Wolfenson served as Derma Sciences Vice President for Marketing and Business Development (from May 2006 to March 2010) and Director of Marketing (from February 2004 through February 2006). Prior to joining Derma Sciences, Mr. Wolfenson worked at Bristol Myers Squibb, where he held various sales and marketing positions since 2001. His last position at Bristol Myers Squibb was as the Marketing Manager of their ConvaTec division. Before his association with Bristol-Myers Squibb, Mr. Wolfenson operated a successful entrepreneurial venture and worked as a management information systems consultant with Andersen Consulting. Mr. Wolfenson earned a Bachelor of Science in Economics from Franklin & Marshall College, Lancaster,Pennsylvania, in 1989, and a Master of Business Administration, cum laude (Phi Beta Kappa) from the University of Michigan, Ann Arbor, Michigan, in 2001.